Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Male Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer
Interventions: DRUG: imatinib mesylate|OTHER: laboratory biomarker analysis
Sponsor: National Cancer Institute (NCI)